| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0008 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |